Skip to main content
Top
Published in: Clinical Rheumatology 7/2012

01-07-2012 | Original Article

Normal QT dispersion in colchicine-resistant familial Mediterranean fever (FMF)

Authors: Udi Nussinovitch, Avi Livneh, Benjamin Volovitz, Moshe Nussinovitch, Ilan Ben-Zvi, Merav Lidar, Naomi Nussinovitch

Published in: Clinical Rheumatology | Issue 7/2012

Login to get access

Abstract

The association between familial Mediterranean fever (FMF) and subclinical cardiac disease remains controversial. The aim of the current study was to evaluate whether FMF patients, who do not respond to colchicine treatment, and thereby endure persistent inflammation, have increased QT dispersion (QTd) values. Twenty-two FMF patients and 22 age- and sex-matched control subjects were included in the study. Repolarization and QT dispersion parameters were computed from 12-lead ECG recording using designated computer software, and results of five beats were subsequently averaged. Both FMF patients and controls had similar comorbidities, similar values of average QT, average corrected QT interval length, average QTd interval, average QT corrected dispersion, QT dispersion ratio, JT dispersion (JTd), and JT corrected dispersion. In conclusion, FMF patients who were unresponsive to colchicine treatment and did not develop amyloidosis had normal QTd and JTd parameters, indicating a non-increased risk for repolarization-associated ventricular arrhythmias.
Literature
1.
go back to reference Padeh S, Livneh A, Pras E, Shinar Y, Lidar M, Feld O, Berkun Y (2010) Familial Mediterranean fever in children presenting with attacks of fever alone. J Rheumatol 37:865–869PubMedCrossRef Padeh S, Livneh A, Pras E, Shinar Y, Lidar M, Feld O, Berkun Y (2010) Familial Mediterranean fever in children presenting with attacks of fever alone. J Rheumatol 37:865–869PubMedCrossRef
2.
go back to reference Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885PubMedCrossRef Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885PubMedCrossRef
3.
go back to reference Sari I, Karaoglu O, Can G, Akar S, Gulcu A, Birlik M, Akkoc N, Tunca M, Goktay Y, Onen F (2007) Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever. Clin Rheumatol 26:1467–1473PubMedCrossRef Sari I, Karaoglu O, Can G, Akar S, Gulcu A, Birlik M, Akkoc N, Tunca M, Goktay Y, Onen F (2007) Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever. Clin Rheumatol 26:1467–1473PubMedCrossRef
4.
go back to reference Akdogan A, Calguneri M, Yavuz B, Arslan EB, Kalyoncu U, Sahiner L, Karadag O, Ertenli I, Kiraz S, Aytemir K, Akata D, Tokgozoglu L, Oto A (2006) Are familial Mediterranean fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in FMF. J Am Coll Cardiol 48:2351–2353PubMedCrossRef Akdogan A, Calguneri M, Yavuz B, Arslan EB, Kalyoncu U, Sahiner L, Karadag O, Ertenli I, Kiraz S, Aytemir K, Akata D, Tokgozoglu L, Oto A (2006) Are familial Mediterranean fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in FMF. J Am Coll Cardiol 48:2351–2353PubMedCrossRef
5.
go back to reference Rozenbaum M, Naschitz JE, Yudashkin M, Sabo E, Shaviv N, Gaitini L, Zuckerman E, Yeshurun D, Rosner I (2004) Cardiovascular reactivity score for the assessment of dysautonomia in familial Mediterranean fever. Rheumatol Int 24:147–152PubMedCrossRef Rozenbaum M, Naschitz JE, Yudashkin M, Sabo E, Shaviv N, Gaitini L, Zuckerman E, Yeshurun D, Rosner I (2004) Cardiovascular reactivity score for the assessment of dysautonomia in familial Mediterranean fever. Rheumatol Int 24:147–152PubMedCrossRef
6.
go back to reference Nussinovitch N, Livneh A, Katz K, Langevitz P, Feld O, Nussinovitch M, Volovitz B, Lidar M, Nussinovitch U (2011) Heart rate variability in familial Mediterranean fever. Rheumatol Int 31:39–43PubMedCrossRef Nussinovitch N, Livneh A, Katz K, Langevitz P, Feld O, Nussinovitch M, Volovitz B, Lidar M, Nussinovitch U (2011) Heart rate variability in familial Mediterranean fever. Rheumatol Int 31:39–43PubMedCrossRef
7.
go back to reference Acar G, Akcay A, Sayarlioglu M, Sokmen A, Sokmen G, Koroglu S, Gunduz M, Ispiroglu M, Tuncer C (2009) Assessment of atrial conduction time in patients with familial Mediterranean fever. Pacing Clin Electrophysiol 32:308–313PubMedCrossRef Acar G, Akcay A, Sayarlioglu M, Sokmen A, Sokmen G, Koroglu S, Gunduz M, Ispiroglu M, Tuncer C (2009) Assessment of atrial conduction time in patients with familial Mediterranean fever. Pacing Clin Electrophysiol 32:308–313PubMedCrossRef
8.
go back to reference Nussinovitch N, Livneh A, Katz K, Nussinovitch M, Volovitz B, Lidar M, Nussinovitch U (2011) P wave dispersion in familial Mediterranean fever. Rheumatol Int 31(12):1591–1594PubMedCrossRef Nussinovitch N, Livneh A, Katz K, Nussinovitch M, Volovitz B, Lidar M, Nussinovitch U (2011) P wave dispersion in familial Mediterranean fever. Rheumatol Int 31(12):1591–1594PubMedCrossRef
9.
go back to reference Akcay A, Acar G, Sayarlioglu M, Sokmen A, Kaya H, Ispiroglu M, Koroglu S (2009) QT dispersion and transmural dispersion of repolarization in patients with familial Mediterranean fever. Mod Rheumatol 19:550–555PubMedCrossRef Akcay A, Acar G, Sayarlioglu M, Sokmen A, Kaya H, Ispiroglu M, Koroglu S (2009) QT dispersion and transmural dispersion of repolarization in patients with familial Mediterranean fever. Mod Rheumatol 19:550–555PubMedCrossRef
10.
go back to reference Nussinovitch N, Livneh A, Katz K, Langevitz P, Feld O, Nussinovitch M, Volovitz B, Lidar M, Nussinovitch U (2010) QT dispersion in uncomplicated familial Mediterranean fever. Clin Rheumatol 29:1353–1356PubMedCrossRef Nussinovitch N, Livneh A, Katz K, Langevitz P, Feld O, Nussinovitch M, Volovitz B, Lidar M, Nussinovitch U (2010) QT dispersion in uncomplicated familial Mediterranean fever. Clin Rheumatol 29:1353–1356PubMedCrossRef
11.
go back to reference Hubacek JA (2009) Eat less and exercise more—is it really enough to knock down the obesity pandemia? Physiol Res 58(Suppl 1):S1–S6PubMed Hubacek JA (2009) Eat less and exercise more—is it really enough to knock down the obesity pandemia? Physiol Res 58(Suppl 1):S1–S6PubMed
12.
go back to reference Goldenberg I, Moss AJ, Zareba W (2006) QT interval: how to measure it and what is “normal”. J Cardiovasc Electrophysiol 17:333–336PubMedCrossRef Goldenberg I, Moss AJ, Zareba W (2006) QT interval: how to measure it and what is “normal”. J Cardiovasc Electrophysiol 17:333–336PubMedCrossRef
13.
go back to reference Malik M, Batchvarov VN (2000) Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol 36:1749–1766PubMedCrossRef Malik M, Batchvarov VN (2000) Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol 36:1749–1766PubMedCrossRef
14.
go back to reference Shah MJ, Wieand TS, Rhodes LA, Berul CI, Vetter VL (1997) QT and JT dispersion in children with long QT syndrome. J Cardiovasc Electrophysiol 8:642–648PubMedCrossRef Shah MJ, Wieand TS, Rhodes LA, Berul CI, Vetter VL (1997) QT and JT dispersion in children with long QT syndrome. J Cardiovasc Electrophysiol 8:642–648PubMedCrossRef
15.
go back to reference Durakovic Z, Misigoj-Durakovic M, Corovic N (2001) Q-T and JT dispersion in the elderly with urban hypothermia. Int J Cardiol 80:221–226PubMedCrossRef Durakovic Z, Misigoj-Durakovic M, Corovic N (2001) Q-T and JT dispersion in the elderly with urban hypothermia. Int J Cardiol 80:221–226PubMedCrossRef
16.
go back to reference Dilaveris P, Gialafos E, Pantazis A, Synetos A, Triposkiadis F, Stamatelopoulos S, Gialafos J (2001) Spatial aspects of ventricular repolarization in postinfarction patients. Pacing Clin Electrophysiol 24:157–165PubMedCrossRef Dilaveris P, Gialafos E, Pantazis A, Synetos A, Triposkiadis F, Stamatelopoulos S, Gialafos J (2001) Spatial aspects of ventricular repolarization in postinfarction patients. Pacing Clin Electrophysiol 24:157–165PubMedCrossRef
17.
go back to reference Shimizu H, Ohnishi Y, Inoue T, Yokoyama M (2001) QT and JT dispersion in patients with monomorphic or polymorphic ventricular tachycardia/ventricular fibrillation. J Electrocardiol 34:119–125PubMedCrossRef Shimizu H, Ohnishi Y, Inoue T, Yokoyama M (2001) QT and JT dispersion in patients with monomorphic or polymorphic ventricular tachycardia/ventricular fibrillation. J Electrocardiol 34:119–125PubMedCrossRef
18.
go back to reference Langevitz P, Livneh A, Neumann L, Buskila D, Shemer J, Amolsky D, Pras M (2001) Prevalence of ischemic heart disease in patients with familial Mediterranean fever. Isr Med Assoc J 3:9–12PubMed Langevitz P, Livneh A, Neumann L, Buskila D, Shemer J, Amolsky D, Pras M (2001) Prevalence of ischemic heart disease in patients with familial Mediterranean fever. Isr Med Assoc J 3:9–12PubMed
Metadata
Title
Normal QT dispersion in colchicine-resistant familial Mediterranean fever (FMF)
Authors
Udi Nussinovitch
Avi Livneh
Benjamin Volovitz
Moshe Nussinovitch
Ilan Ben-Zvi
Merav Lidar
Naomi Nussinovitch
Publication date
01-07-2012
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 7/2012
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-012-1982-8

Other articles of this Issue 7/2012

Clinical Rheumatology 7/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine